Estimating the number of people who inject drugs in New York
Estimating the population size of persons who inject drugs in New York
This study is trying to find out how many people in New York inject drugs so we can better understand their health risks and improve services to help prevent HIV and hepatitis C infections among them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10741123 on NIH RePORTER |
What this research studies
This research aims to accurately estimate the population size of individuals who inject drugs (PWID) in New York, which is crucial for addressing the rising rates of HIV and hepatitis C infections linked to unsafe injection practices. By utilizing a method called multiple systems estimation (MSE), the study will analyze existing administrative data and survey responses from PWID to determine the size of this population and their specific health risks. The findings will help inform public health strategies and resource allocation for prevention services aimed at reducing infectious diseases among this vulnerable group.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and reside in New York, particularly those at risk for HIV and hepatitis C.
Not a fit: Patients who do not inject drugs or those who live outside of New York may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective allocation of resources and improved health outcomes for individuals at risk of HIV and hepatitis C infections.
How similar studies have performed: Previous research using similar estimation methods has shown success in accurately assessing hidden populations, indicating that this approach is promising.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Bradley, Heather — Emory University
- Study coordinator: Bradley, Heather
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.